EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Screening of serum biomarkers in patients with PCOS through lipid omics and ensemble machine learning

Ji-Ying Chen iD, Wu-Jie Chen, Zhi-Ying Zhu, Shi Xu, Li-Lan Huang, Wen-Qing Tan, Yong-Gang Zhang, Yan-Li Zhao

PLOS ONE · 07.01.2025 · 20 (1) · e0313494

DOI: 10.1371/journal.pone.0313494 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 07.01.2025. Verfasst von Ji-Ying Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Shenzhen Longhua District Central Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Biomarkers, Machine Learning. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Laboratory of Science and Technology Innovation, Scientific Research Projects of Medical and Health Institutions of Longhua District.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a primary endocrine disorder affecting premenopausal women involving metabolic dysregulation. We aimed to screen serum biomarkers in PCOS patients using untargeted lipidomics and ensemble machine learning. Serum from PCOS patients and non-PCOS subjects were collected for untargeted lipidomics analysis. Through analyzing the classification of differential lipid metabolites and the association between differential lipid metabolites and clinical indexes, ensemble machine learning, data preprocessing, statistical test pre-screening, ensemble learning method secondary screening, biomarkers verification and evaluation, and diagnostic panel model construction and verification were performed on the data of untargeted lipidomics. Results indicated that different lipid metabolites not only differ between groups but also have close effects on different corresponding clinical indexes. PI (18:0/20:3)-H and PE (18:1p/22:6)-H were identified as candidate biomarkers. Three machine learning models, logistic regression, random forest, and support vector machine, showed that screened biomarkers had better classification ability and effect. In addition, the correlation of candidate biomarkers was low, indicating that the overlap between the selected biomarkers was low, and the combination of panels was more optimized. When the AUC value of the test set of the constructed diagnostic panel model was 0.815, the model’s accuracy in the test set was 0.74, specificity was 0.88, and sensitivity was 0.7. This study demonstrated the applicability and robustness of machine learning algorithms to analyze lipid metabolism data for efficient and reliable biomarker screening. PI (18:0/20:3)-H and PE (18:1p/22:6)-H showed great potential in diagnosing PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeBiomarkersMachine LearningHumansFemaleAdultLipidomicsLipidsYoung Adult

Substanzen

BiomarkersLipids

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Shenzhen Longhua District Central Hospital, Shenzhen, China.
  • Department of Medical Laboratory, Shenzhen Longhua District Central Hospital, Shenzhen, China.
  • Department of General Practice, Shenzhen Longhua District Central Hospital, Shenzhen, China.
  • Department of Clinical Laboratory, Shenzhen Longhua District Central Hospital, Shenzhen, China.

ORCID-Profile: Ji-Ying Chen

Förderung

  • Key Laboratory of Science and Technology Innovation
  • Scientific Research Projects of Medical and Health Institutions of Longhua District

Zitieren

APA

Chen, J. Y., Chen, W. J., Zhu, Z. Y., Xu, S., Huang, L. L., Tan, W. Q., Zhang, Y. G., & Zhao, Y. L. (2025). Screening of serum biomarkers in patients with PCOS through lipid omics and ensemble machine learning. PLOS ONE, 20(1), e0313494. https://doi.org/10.1371/journal.pone.0313494

Vancouver

Chen JY, Chen WJ, Zhu ZY, Xu S, Huang LL, Tan WQ, et al. Screening of serum biomarkers in patients with PCOS through lipid omics and ensemble machine learning. PLOS ONE. 2025;20(1):e0313494. doi:10.1371/journal.pone.0313494

BibTeX
@article{Chen2025,
  author = {Chen, Ji-Ying and Chen, Wu-Jie and Zhu, Zhi-Ying and Xu, Shi and Huang, Li-Lan and Tan, Wen-Qing and Zhang, Yong-Gang and Zhao, Yan-Li},
  title = {Screening of serum biomarkers in patients with PCOS through lipid omics and ensemble machine learning},
  journal = {PLOS ONE},
  year = {2025},
  volume = {20},
  number = {1},
  pages = {e0313494},
  doi = {10.1371/journal.pone.0313494}
}
Kostenlos starten →